Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of$ 0.12. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -8.33%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.11 per share when it actually produced a loss of $0.03, delivering a surprise of 72.73%.Over the last four qu ...